Tratamiento de la infección crónica por VHC en pacientes coinfectados por el VIH

Autor: Fuertes Martín A, Alvarez Delgado A, Pérez García Ml

Publikováno v: Anales de Medicina Interna v.22 n.6 2005
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

El tratamiento de la infección por el virus de la hepatitis C (VHC) en los pacientes coinfectados por el virus de la inmunodeficiencia humana (VIH) se ha convertido en un tema de gran importancia, ya que las complicaciones de la hepatopatía son act

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e6790297b2185c53aaa83eeec924e94
https://doi.org/10.4321/s0212-71992005000600009

Permeation Protection by Waterproofing Mucosal Membranes.

Autor: Coderch L; Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain., Alonso C; Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain., Calpena AC; Department de Farmàcia i Tecnologia Farmacèutica, i Fisicoquímica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.; Institut de Nanociència i Nanotecnologia UB (IN2UB), Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain., Pérez-García ML; Institut de Nanociència i Nanotecnologia UB (IN2UB), Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain.; Departament de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, Avda. Joan XXIII 27-31, 08028 Barcelona, Spain., Clares-Naveros B; Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of Granada, 18071 Granada, Spain.; Biosanitary Research Institute of Granada (ibs GRANADA), Avda de Madrid 15, 18012 Granada, Spain., Ramos A; Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain., Martí M; Surfactants and Nanobiotechnology Department, Institute of Advanced Chemical of Catalonia of CSIC (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.

Publikováno v: Pharmaceutics [Pharmaceutics] 2023 Nov 29; Vol. 15 (12). Date of Electronic Publication: 2023 Nov 29.

Functional Alterations Involved in Increased Bleeding in Hereditary Hemorrhagic Telangiectasia Mouse Models.

Autor: Egido-Turrión C; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Rossi E; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Paris, France., Ollauri-Ibáñez C; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Pérez-García ML; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, Complejo Asistencial Universitario de Salamanca (CAUSA)-SACYL, Salamanca, Spain., Sevilla MA; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Bastida JM; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA)-SACYL, Salamanca, Spain., González-Porras JR; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA)-SACYL, Salamanca, Spain., Rodríguez-Barbero A; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Bernabeu C; Centro de Investigaciones Biológicas Margarita Salas, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Lopez-Novoa JM; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Pericacho M; Department of Physiology and Pharmacology, Universidad de Salamanca, Salamanca, Spain.; Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2022 May 19; Vol. 9, pp. 871903. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022).

Development of a severity of disease score and classification model by machine learning for hospitalized COVID-19 patients.

Autor: Marcos M; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Belhassen-García M; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Sánchez-Puente A; Department of Cardiology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Sampedro-Gomez J; Department of Cardiology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Azibeiro R; Department of Hematology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Dorado-Díaz PI; Department of Cardiology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Marcano-Millán E; Department of Intensive Care Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., García-Vidal C; Department of Infectious Diseases, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain., Moreiro-Barroso MT; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Cubino-Bóveda N; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Pérez-García ML; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Rodríguez-Alonso B; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Encinas-Sánchez D; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Peña-Balbuena S; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Sobejano-Fuertes E; Department of Hematology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Inés S; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Carbonell C; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., López-Parra M; Department of Hematology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Andrade-Meira F; Department of Infectious Diseases, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain., López-Bernús A; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Lorenzo C; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Carpio A; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Polo-San-Ricardo D; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Sánchez-Hernández MV; Department of Anesthesiology and Reanimation, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Borrás R; Department of Emergency Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Sagredo-Meneses V; Department of Intensive Care Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain., Sanchez PL; Department of Cardiology, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain., Soriano A; Department of Infectious Diseases, Hospital Clínic-Universitat de Barcelona, IDIBAPS, Barcelona, Spain., Martín-Oterino JÁ; Department of Internal Medicine, University Hospital of Salamanca-IBSAL, University of Salamanca, Salamanca, Spain.

Publikováno v: PloS one [PLoS One] 2021 Apr 21; Vol. 16 (4), pp. e0240200. Date of Electronic Publication: 2021 Apr 21 (Print Publication: 2021).

[Treatment of chronic hepatitis C virus infection in human immunodeficiency virus (HIV) infected patients].

Autor: Pérez García ML; Servicio de Medicina Interna II, Hospital Universitario de Salamanca. marisapergar@hotmail.com, Alvarez Delgado A, Fuertes Martín A

Publikováno v: Anales de medicina interna (Madrid, Spain : 1984) [An Med Interna] 2005 Jun; Vol. 22 (6), pp. 288-92.